Characteristic | Patient | |
---|---|---|
No | % | |
Sex | ||
Male | 26 | 56.5 |
Female | 20 | 43.5 |
Age, years | ||
Median | 51 | |
Range | 23-68 | |
ECOG performance status | ||
0 | 8 | 17.4 |
1 | 36 | 78.3 |
2 | 2 | 4.3 |
Prior Therapy | 46 | |
Chemotherapy (including cytokine and TKI) | ||
1 | 21 | |
2 | 10 | |
≥3 | 15 | |
Radiotherapy | 13 | |
Surgery | 39 | |
Other (Endocrine/Intervention) | 7 | |
Measurability of baseline disease | ||
Measurable | 45 | 97.8 |
Unmeasurable | 1 | 2.1 |
Primary tumor site | ||
Gastrointestinal tract | 34 | 73.9 |
Bronchus/Lung | 3 | 6.5 |
Breast | 3 | 6.5 |
Other | 6 | 13 |